Prempro News
Most Popular Prempro Story
Pfizer defends Wyeth's conduct on HRT
Pfizer fights back: The drugmaker issued a statement today responding to the New York Times' big take-out on hormone replacement therapy. According to the company, the newspaper's coverage Read more...
Latest Headlines
- December 15, 2011
- December 9, 2011
- December 7, 2011
- February 10, 2011
- February 9, 2011
- January 3, 2011
- October 20, 2010
- October 5, 2010
- September 8, 2010
- August 30, 2010
- August 19, 2010
- June 21, 2010
- February 25, 2010
- February 23, 2010
- December 14, 2009
- November 23, 2009
- November 5, 2009
- October 27, 2009
- February 5, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
